Intravenous non-high-dose pantoprazole is equally effective as high-dose pantoprazole in preventing rebleeding among low risk patients with a bleeding peptic ulcer after initial endoscopic hemostasis

Autor: Liang Chih-Ming, Lee Jyong-Hong, Kuo Yuan-Hung, Wu Keng-Liang, Chiu Yi-Chun, Chou Yeh-Pin, Hu Ming-Luen, Tai Wei-Chen, Chiu King-Wah, Hu Tsung-Hui, Chuah Seng-Kee

Publikováno v: BMC Gastroenterology, Vol 12, Iss 1, p 28 (2012)

Abstract Background Many studies have shown that high-dose proton-pumps inhibitors (PPI) do not further reduce the rate of rebleeding compared to non-high-dose PPIs but we do not know whether intravenous non-high-dose PPIs reduce rebleeding rates amo

Externí odkaz: https://doaj.org/article/6c2cdeb141f04af4afa76920418b591e

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The Pattern of Intravenous Proton-Pump Inhibitor Utilization at an Academic Medical Center in Riyadh, Saudi Arabia.

Autor: Mohzari YA; Department of Clinical Pharmacy, KSMC, Riyadh, Saudi Arabia., Alsaegh A; Department of Clinical Pharmacy, KSMC, Riyadh, Saudi Arabia., Basheeruddin Asdaq SM; Department of Pharmacology, College of Pharmacy, Al-Maarefa University, Riyadh, Saudi Arabia., Al Shanawani SN; Department of Pharmaceutical Care Services, KSMC, Riyadh, Saudi Arabia., Albraiki AA; Department of Inpatient Pharmacies, KSMC, Riyadh, Saudi Arabia., Bagalb A; Department of Pharmaceutical Care Services, KSMC, Riyadh, Saudi Arabia.

Publikováno v: Journal of research in pharmacy practice [J Res Pharm Pract] 2020 Oct 08; Vol. 9 (3), pp. 151-154. Date of Electronic Publication: 2020 Oct 08 (Print Publication: 2020).